银华中证创新药产业ETF(159992)资产负债表
| |
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
116,740,986.45 |
| 结算备付金 |
10,876,341.97 |
2,670,937.69 |
5,931,368.41 |
4,229,129.81 |
| 存出保证金 |
1,365,563.46 |
1,195,547.09 |
1,390,304.69 |
1,725,281.51 |
| 交易性金融资产 |
9,795,057,112.73 |
6,257,528,520.42 |
8,523,135,865.37 |
7,621,209,786.42 |
| 其中：股票投资 |
9,795,057,112.73 |
6,257,528,520.42 |
8,523,135,865.37 |
7,621,209,786.42 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
10,300,696.87 |
16,235,194.10 |
14,877,745.81 |
3,343,789.65 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
24,840.00 |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
48,377.50 |
17,117.40 |
| 资产总计 |
9,960,329,175.55 |
6,416,962,549.46 |
8,793,568,778.41 |
7,747,290,931.24 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
26,309,779.27 |
59,292,475.14 |
43,334,851.59 |
7,981,100.62 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
4,412,826.77 |
2,697,038.22 |
3,705,488.43 |
3,206,407.07 |
| 应付托管费 |
441,282.68 |
269,703.80 |
370,548.85 |
320,640.74 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
4,993.50 |
11,757.82 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
1,691,739.92 |
2,052,207.26 |
2,427,706.10 |
4,505,057.79 |
| 负债合计 |
32,855,628.64 |
64,311,424.42 |
49,843,588.47 |
16,024,964.04 |
| 所有者权益 |
| 实收基金 |
14,257,781,217.00 |
10,359,581,217.00 |
10,592,981,217.00 |
9,416,381,217.00 |
| 未分配利润 |
-4,330,307,670.09 |
-4,006,930,091.96 |
-1,849,256,027.06 |
-1,685,115,249.80 |
| 所有者权益合计 |
9,927,473,546.91 |
6,352,651,125.04 |
8,743,725,189.94 |
7,731,265,967.20 |
| 负债及所有者权益总计 |
9,960,329,175.55 |
6,416,962,549.46 |
8,793,568,778.41 |
7,747,290,931.24 |
微信公众号
证券之星APP
基本资料
